Case details

Print
Merger control
Case reference
Ccent/2018/25 - ICG / Suanfarma
Acquiring
Intermediate Capital Group, plc
Description
Company active in asset management.
Acquired
Suanfarma, S.A.
Description
Company active in the pharmaceutical sector.
Sector
  • Extractive and manufacturing Industries
Activity (NACE)
  • C21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
Applicable legislation
Art. 37(1)(a) (Law 19)
Notification thresholds
Market Share threshold
Type of merger
Conglomerate
Cooperation with sector regulators
Status
Closed
Type of Investigation
Phase 1
AdC’s decision
Case description
The notified concentration consists of the acquisition of sole control over Suanfarma by ICG
Timeline
Click here to see your activities